Schedule effect of recombinant human thrombopoietin (rhTPO) in attenuating thrombocytopenia in patients receiving dose intensive chemotherapy with adriamycin (A) and ifosfamide (I).

被引：0
|
作者：
Vadhan-Raj, S
Patel, S
Broxmeyer, HE
Bueso-Ramos, CE
Hangoc, G
Papadopolous, NE
Burgess, MA
Plager, C
Brown, CA
Hays, CF
Benjamin, RS
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Indiana Univ, Indianapolis, IN 46204 USA
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1957
引用
收藏
页码：455A / 455A
页数：1
相关论文
共 50 条
  • [21] Multicenter, randomized study of genetically modified recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in cancer patients receiving chemotherapy
    Wu, Shikai
    Zhang, Yang
    Xu, Liyan
    Dai, Yun
    Teng, Yuee
    Ma, Shanshan
    Ho, Seong-Hyun
    Kim, Jong-Mook
    Yu, Seung Shin
    Kim, Sunyoung
    Song, Santai
    SUPPORTIVE CARE IN CANCER, 2012, 20 (08) : 1875 - 1884
  • [22] Multicenter, randomized study of genetically modified recombinant human interleukin-11 to prevent chemotherapy-induced thrombocytopenia in cancer patients receiving chemotherapy
    Shikai Wu
    Yang Zhang
    Liyan Xu
    Yun Dai
    Yuee Teng
    Shanshan Ma
    Seong-Hyun Ho
    Jong-Mook Kim
    Seung Shin Yu
    Sunyoung Kim
    Santai Song
    Supportive Care in Cancer, 2012, 20 : 1875 - 1884
  • [23] Recombinant Human Thrombopoietin (rhTPO) and High-Dose Dexamethasone (HD-DXM) Versus High-Dose Dexamethasone Monotherapy As Frontline Treatment in Newly Diagnosed Adult Immune Thrombocytopenia (ITP): a Prospective, Multicentre, Randomised, Controlled Trial
    Wang, Miaomiao
    Qin, Ping
    Zhou, Hai
    Zhou, Fang
    Zhao, Hongguo
    Wang, Xin
    Xu, Ruirong
    Li, Daqi
    Wang, Lei
    Zhou, Yuhong
    Feng, Ying
    Zhang, Mei
    Yang, Lan
    Wang, Xiaomin
    Zeng, Qingshu
    Zhang, Haiyan
    Sun, Zhaogang
    Wang, Jingxia
    Liu, Guoqiang
    Guo, Xinhong
    Wang, Zhencheng
    Yu, Wenzheng
    Chu, Xiaoxia
    Yuan, Chenglu
    Bi, Kehong
    Wang, Yili
    Ran, Xuehong
    Peng, Jun
    Hou, Ming
    BLOOD, 2017, 130
  • [24] EFFECT OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING CHEMOTHERAPY FOR UROGENITAL CANCER
    ASO, Y
    AKAZA, H
    JOURNAL OF UROLOGY, 1992, 147 (04): : 1060 - 1064
  • [25] RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING INTENSIVE CHEMOTHERAPY FOR NONSMALL CELL LUNG-CANCER
    MORI, K
    SAITOH, Y
    TOMINAGA, K
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (05) : 677 - 680
  • [26] Optimized Recombinant Human Thrombopoietin(rhTPO) Regimen Versus Eltrombopag for Pre-Treated Patients with Primary Immune Thrombocytopenia: Interim Results from a Prospective, Multicenter, Randomized Trial (TE-ITP study)
    Chen, Yunfei
    Sun, Ting
    Gao, Da
    Wang, Wei
    Zhou, Zeping
    Gao, Guangxun
    Wang, Yi
    Zhou, Hu
    Song, Yanping
    Lai, Yinghui
    Yan, Zhenyu
    Yan, Jinsong
    Hai, Jie
    Zhang, Lei
    BLOOD, 2024, 144 : 3937 - 3938
  • [27] PHASE-I/II STUDY OF RECOMBINANT HUMAN GRANULOCYTE COLONY-STIMULATING FACTOR IN PATIENTS RECEIVING INTENSIVE CHEMOTHERAPY FOR SMALL CELL LUNG-CANCER
    BRONCHUD, MH
    SCARFFE, JH
    THATCHER, N
    CROWTHER, D
    SOUZA, LM
    ALTON, NK
    TESTA, NG
    DEXTER, TM
    BRITISH JOURNAL OF CANCER, 1987, 56 (06) : 809 - 813
  • [28] Protective effect of human recombinant interleukin-1β (betaleukin) on leukopoiesis in patients receiving anticancer chemotherapy.
    Gershanovich, ML
    Filatova, L
    Ketlinsky, S
    Simbirtzev, A
    ANNALS OF ONCOLOGY, 2000, 11 : 142 - 142
  • [29] Effect of recombinant human erythropoietin on quality of life in cancer patients receiving chemotherapy: Results of a randomized, controlled trial
    Iconomou, G
    Koutras, A
    Rigopoulos, A
    Vagenakis, AG
    Kalofonos, HP
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2003, 25 (06) : 512 - 518
  • [30] Randomized trial of recombinant human granulocyte-macrophage colony-stimulating factor in pediatric patients receiving intensive myelosuppressive chemotherapy
    Wexler, LH
    WeaverMcClure, L
    Steinberg, SM
    Jacobson, J
    Jarosinski, P
    Avila, N
    Pizzo, PA
    Horowitz, ME
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) : 901 - 910
12345